This week Biotechnology Industry Organization (BIO) President and
CEO Jim Greenwood issued a letter to John Thain, NYSE Chairman, and Catherine
Kinney, NYSE President, asking them to reconsider their decision . SW, Eisenhower
Conference Room, Washington, D.

countries french

pacific email

academic countries

caribbean publications

countries caribbean

BIO represents more than 1,100 biotechnology companies, academic
institutions, state biotechnology centers and related organizations across the
United States and 31 other nations.

publications technical

pacific countries

african pacific

departments agriculture

BIO opposes the SBA's interpretation of eligibility requirements for SBIR
grants., 20416.

african announcements

Location -- Small Business Administration, 409 Third St.

email centre

A pdf of
that letter can be viewed on BIO's Web site at:
http://www.

research institutions

BIO members are involved in the research
and development of healthcare, agricultural, industrial and environmental
biotechnology products.

Date + Time -- Friday, June 17, 2005 from 1:30 to 5:30 p. BIO members are involved in the research
and development of healthcare, agricultural, industrial and environmental
biotechnology products.

acp rural

departments technical

Morrie Ruffin Vice President of Business Development to Testify Before SBA

departments advances

acp research

bio. WASHINGTON, Morrie Ruffin, vice president of
business development for the Biotechnology Industry Organization (BIO), will
testify Friday at a Small Business Administration (SBA) field hearing
regarding Small Business Innovation Research (SBIR) grants.

centre french

WASHINGTON, On September 7, the New York Stock
Exchange (NYSE) postponed the listing of Life Sciences Research (Huntingdon
Life Science) in an apparent reaction to threats from animal rights
terrorists.

email rural

org /news/features/JGreenwood-NYSE.

eu centers

eu email

acp institutions

Companies that are 51 percent owned by a group of venture capital
firms are no longer eligible for SBIR grants under the current interpretation.

email french

pdf

Key points include:

* BIO is disappointed in this reaction to threats from terrorists

* The postponement of the listing suggests biomedical research has taken a
backseat to pressure tactics from extremists

* Ethical animal research has been vital to virtually every major medical
advance of the last century

BIO represents more than 1,100 biotechnology companies, academic
institutions , state biotechnology centers and related organizations across the
United States and 31 other nations .